Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 1/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4079497 | 1.00 | GRIN1 (0.41) | GRIN1GRIN2BEPHX1CES2CES1 | |
| SCHEMBL3114037 | 1.00 | GRIN1 (0.41) | GRIN1GRIN2BEPHX1CES2CES1 | |
| SCHEMBL532572 | 0.98 | GRIN1 (0.39) | GRIN1GRIN2BEPHX1CES2CES1 | |
| SCHEMBL4743867 | 0.93 | — | — | |
| SCHEMBL730203 | 0.87 | HDAC2 (0.34) | GRIN1GRIN2B | |
| SCHEMBL543403 | 0.87 | — | — | |
| SCHEMBL761935 | 0.80 | CES2 (0.38) | GRIN1GRIN2BEPHX1CES2CES1 | |
| SCHEMBL6360578 | 0.79 | EPHX2 (0.33) | — | |
| SCHEMBL23749603 | 0.78 | HTT (0.47) | GRIN1GRIN2BCES2CES1GRIK1 | |
| SCHEMBL9743609 | 0.78 | HTT (0.47) | GRIN1GRIN2BCES2CES1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 432 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2026-02-05 | — | — | US | claimed |
| EP-4562077-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NewSouth Innovations Pty Limited (AU) | 2025-06-04 | — | — | EP | claimed |
| WO-2024020649-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2024-02-01 | — | — | WO | claimed |
| WO-2022261721-A1 | HEALABLE AND REPROCESSABLE COMPOSITIONS | DEAKIN UNIVERSITY (AU) | 2022-12-22 | — | — | WO | claimed |
| US-9631132-B2 | Mitigating annular pressure buildup using temperature-activated polymeric particulates | HALLIBURTON ENERGY SERVICES, INC. (US) | 2017-04-25 | — | — | US | claimed |
| WO-2015006574-A1 | MITIGATING ANNULAR PRESSURE BUILDUP USING TEMPERATURE-ACTIVATED POLYMERIC PARTICULATES | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-01-15 | — | — | WO | claimed |
| WO-2014088850-A2 | SHALE SWELLING INHIBITORS | ISP INVESTMENTS INC. (US) | 2014-06-12 | — | — | WO | claimed |
| WO-2011141522-A1 | BIODEGRADABLE SUPERABSORBER | GEOHUMUS INTERNATIONAL RESEARCH & DEVELOPMENT GMBH (DE) | 2011-11-17 | — | — | WO | claimed |
| EP-2379669-A1 | METHOD FOR BLOCKING SUBTERRANEAN FORMATIONS | BASF SE (DE) | 2011-10-26 | — | — | EP | claimed |
| US-7815835-B2 | Rapid prototyping method and radiation-curable composition for use therein | TECHNISCHE UNIVERSITAT WIEN (AT) | 2010-10-19 | — | — | US | claimed |
| EP-1907192-B1 | RAPID-PROTOTYPING METHOD AND USE IN THE METHOD OF A RADIATION-HARDENABLE COMPOSITION | UNIV WIEN TECH (AT) | 2008-11-19 | — | — | EP | claimed |
| EP-1776176-A1 | COMPOSITE MATERIAL COMPRISING A NON-CROSSLINKED GEL POLYMER | McMaster University (CA) | 2007-04-25 | — | — | EP | claimed |
| US-20060074142-A1 | Aqueous inks containing colored polymers | XEROX CORPORATION | 2006-04-06 | — | — | US | claimed |
| WO-2006015495-A1 | COMPOSITE MATERIAL COMPRISING A NON-CROSSLINKED GEL POLYMER | MCMASTER UNIVERSITY (CA) | 2006-02-16 | — | — | WO | claimed |
| EP-1530600-A1 | BIO-SYNTHETIC MATRIX AND USES THEREOF | Ottawa Health Research Institute (CA) | 2005-05-18 | — | — | EP | claimed |
| WO-2004014969-A1 | BIO-SYNTHETIC MATRIX AND USES THEREOF | OTTAWA HEALTH RESEARCH INSTITUTE (CA) | 2004-02-19 | — | — | WO | claimed |
| WO-2004015090-A2 | INNERVATED ARTIFICIAL TISSUES AND USES THEREOF | OTTAWA HEALTH RESEARCH INSTITUTE (CA) | 2004-02-19 | — | — | WO | claimed |
| EP-0774096-A4 | A METHOD FOR INHIBITING HYDRATE FORMATION | EXXON PRODUCTION RESEARCH CO (US) | 1999-01-13 | — | — | EP | claimed |
| EP-0774096-A1 | A METHOD FOR INHIBITING HYDRATE FORMATION | EXXON PRODUCTION RESEARCH COMPANY (US) | 1997-05-21 | — | — | EP | claimed |
| WO-1996008672-A1 | A METHOD FOR INHIBITING HYDRATE FORMATION | EXXON PRODUCTION RESEARCH COMPANY (US) | 1996-03-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | PIEZO1, LCP1, MTCL3 | GRIN1 619/4885GRIN2B 991/4885EPHX1 3699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.